Page 3 - Dr Reddy's Laboratories Limited

Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs

Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study

Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait

Sensex up 248 pts at 49,517; Nifty at 14,563; SBI, Airtel soar 4%, RIL 3%

Stock market updates: Nifty PSU Bank index surged over 6 per cent and was the top sectoral gainer

PM holds virtual meet with teams developing, manufacturing Covid-19 vaccine

The teams were from Gennova Biopharmaceuticals Ltd in Pune, Biological E Ltd and Dr Reddys Laboratories Ltd in Hyderabad.

Dr Reddy's gets nod for 2/3 vaccine trial; Key updates about the virus

A PMO release said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III

Strong support exists for Nifty at 10,900: CapitalVia Global Research

A short-covering move, along with addition of fresh position, is seen only if somehow Nifty sustains level of 11,200

Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks

The next upside for Nifty Pharma is located above the resistance of 12,100 levels.

Dr Reddy's Labs gains for second straight day on Covid vaccine deal

Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine

New launches, patents: Multiple catalysts for Dr Reddy's US business

The ongoing pace of product launches in the US should lead to stronger growth after a good Q1, say analysts

Dr Reddy's launches cancer drug Abiraterone Acetate in US market

The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson

Dr Reddy's closes Wockhardt branded generics deal on modified terms

Under new terms, DRL to hold back Rs 300 crore and release it if the revenue from sale of the products forming part of the business undertaking during the 12 months post-closing exceeds Rs 480 cr

Centre keen on testing Gilead's remdesivir to combat coronavirus

The USFDA has recently given an emergency approval to the drug for use on coronavirus patients

Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility

The company said, with this, all facilities under warning letter are now determined as Voluntary Action Indicated (VAI)

India gears up for patient trials on 20 different drugs for Covid-19

Local pharma units have already started work on developing patented drugs, some have already approached regulator for approvals

Dr Reddy's denies reports it is in talks with Gilead for Covid-19 antiviral

Patient groups urge govt to revoke Gilead's remedesivir patent in the wake of the crisis

Dr Reddy's launches generic Ziprasidone Mesylate for injection in US

It's the therapeutic generic equivalent of Geodon Injections

Dr Reddy's gets 1 observation from USFDA after inspecting Hyderabad plant

Earlier, the drug major had said that the US health regulator has issued a Form 483 with two observations after inspecting the facility but later it was issued revised Form 483 with one observation

Dr Reddy's gets nod for amalgamation of Dr Reddy's Holdings into company

21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added

China opens public hospitals for Dr Reddy's Laboratories generic drugs

First Indian firm to get contract for supplying generic schizophrenia drug to public hospitals there